IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex reports huge rise in profits

5:46 AM MDT | August 1, 2014 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reports a more than eightfold increase in net profits for the second quarter of 2014 compared with the second quarter of 2013, to $19.66 million. Second-quarter sales increased 58.1%, to $97.34 million. The company recorded sales increases in all of its product categories, with strong growth in certain branded active pharmaceutical ingredients (APIs), controlled substances, and generic APIs, Cambrex says.  Pricing was lower by about 1.8% compared with the second quarter of last year. For the first six months of 2014, Cambrex...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa